R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT05784987 · UNKNOWN
Trial details
- NCT number
- NCT05784987
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-15
- Primary completion
- 2024-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.